View in EDS

Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT.

Saved in:
Bibliographic Details
Title: Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT.
Authors: Burger PM; Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht 3584 CX, the Netherlands., Bhatt DL; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, NY 10029, USA., Dorresteijn JAN; Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht 3584 CX, the Netherlands., Koudstaal S; Dutch Cardiovascular Research Network (WCN), Utrecht 3511 EP, the Netherlands.; Department of Cardiology, Green Heart Hospital, Gouda 2803 HH, the Netherlands., Mosterd A; Dutch Cardiovascular Research Network (WCN), Utrecht 3511 EP, the Netherlands.; Department of Cardiology, Meander Medical Centre, Amersfoort 3813 TZ, the Netherlands., Martens FMAC; Dutch Cardiovascular Research Network (WCN), Utrecht 3511 EP, the Netherlands.; Department of Cardiology, Amsterdam University Medical Centre, Amsterdam 1105 AZ, the Netherlands., Steg PG; Université Paris-Cité, LVTS, French Alliance for Cardiovascular Trials (FACT), Assistance Publique-Hôpitaux de Paris, Paris 75018, France., Visseren FLJ; Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht 3584 CX, the Netherlands.
Corporate Authors: REDUCE-IT Investigators
Source: European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2024 Oct 04; Vol. 10 (6), pp. 488-499.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101669491 Publication Model: Print Cited Medium: Internet ISSN: 2055-6845 (Electronic) NLM ISO Abbreviation: Eur Heart J Cardiovasc Pharmacother Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38678009
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Burger+PM%22">Burger PM</searchLink>; Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht 3584 CX, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Bhatt+DL%22">Bhatt DL</searchLink>; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, NY 10029, USA.<br /><searchLink fieldCode="AU" term="%22Dorresteijn+JAN%22">Dorresteijn JAN</searchLink>; Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht 3584 CX, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Koudstaal+S%22">Koudstaal S</searchLink>; Dutch Cardiovascular Research Network (WCN), Utrecht 3511 EP, the Netherlands.; Department of Cardiology, Green Heart Hospital, Gouda 2803 HH, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Mosterd+A%22">Mosterd A</searchLink>; Dutch Cardiovascular Research Network (WCN), Utrecht 3511 EP, the Netherlands.; Department of Cardiology, Meander Medical Centre, Amersfoort 3813 TZ, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Martens+FMAC%22">Martens FMAC</searchLink>; Dutch Cardiovascular Research Network (WCN), Utrecht 3511 EP, the Netherlands.; Department of Cardiology, Amsterdam University Medical Centre, Amsterdam 1105 AZ, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Steg+PG%22">Steg PG</searchLink>; Université Paris-Cité, LVTS, French Alliance for Cardiovascular Trials (FACT), Assistance Publique-Hôpitaux de Paris, Paris 75018, France.<br /><searchLink fieldCode="AU" term="%22Visseren+FLJ%22">Visseren FLJ</searchLink>; Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht 3584 CX, the Netherlands.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22REDUCE-IT+Investigators%22">REDUCE-IT Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101669491%22">European heart journal. Cardiovascular pharmacotherapy</searchLink> [Eur Heart J Cardiovasc Pharmacother] 2024 Oct 04; Vol. 10 (6), pp. 488-499.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101669491 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2055-6845 (Electronic) <i>NLM ISO Abbreviation: </i>Eur Heart J Cardiovasc Pharmacother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38678009
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/ehjcvp/pvae030
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 488
    Titles:
      – TitleFull: Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Burger PM
      – PersonEntity:
          Name:
            NameFull: Bhatt DL
      – PersonEntity:
          Name:
            NameFull: Dorresteijn JAN
      – PersonEntity:
          Name:
            NameFull: Koudstaal S
      – PersonEntity:
          Name:
            NameFull: Mosterd A
      – PersonEntity:
          Name:
            NameFull: Martens FMAC
      – PersonEntity:
          Name:
            NameFull: Steg PG
      – PersonEntity:
          Name:
            NameFull: Visseren FLJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 10
              Text: 2024 Oct 04
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2055-6845
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: European heart journal. Cardiovascular pharmacotherapy
              Type: main
ResultId 1